Search research articles
Contact Us
Filters
Showing results (11-20 of 26) with videos related to
Page
of 3
Sort By:
Journal of Neuroinflammation
|
April 17, 2015
Role of high mobility group box protein 1 (HMGB1) in peripheral blood from patients with multiple sclerosis
Sunny Malhotra, Nicolas Fissolo, Mar Tintoré, et al.
Blood
|
November 5, 2005
AID expression identifies interfollicular large B cells as putative precursors of mature B-cell malignancies
Gerhard Moldenhauer, Sergey W Popov, Beate Wotschke, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 21, 2009
Advanced intercross line mapping suggests that ncf1 (ean6) regulates severity in an animal model of guillain-barre syndrome
Alexander Huberle, Amennai Daniel Beyeen, Johan Ockinger, et al.
Frontiers in Immunology
|
August 10, 2023
Molecular signature associated with cladribine treatment in patients with multiple sclerosis
Nicolas Fissolo, Laura Calvo-Barreiro, Herena Eixarch, et al.
European Journal of Neurology
|
May 15, 2023
The CYP24A1 gene variant rs2762943 is associated with low serum 1,25-dihydroxyvitamin D levels in multiple sclerosis patients
Sunny Malhotra, Luciana Midaglia, Omar Chuquisana, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
July 10, 2018
Cerebrospinal fluid mitochondrial DNA levels in patients with multiple sclerosis
Nicolas Fissolo, Laura Cervera-Carles, Luisa María Villar Guimerans, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
September 9, 2021
CSF Chitinase 3-Like 2 Is Associated With Long-term Disability Progression in Patients With Progressive Multiple Sclerosis
Manuel Comabella, Jaume Sastre-Garriga, Eva Borras, et al.
Clinical and Translational Medicine
|
April 9, 2024
Clusterin deficiency is associated with a lack of response to teriflunomide in multiple sclerosis
Sunny Malhotra, Nicolas Fissolo, Carmen Rodríguez-Rivera, et al.
JCI Insight
|
June 8, 2018
Monocyte NOTCH2 expression predicts IFN-β immunogenicity in multiple sclerosis patients
Marsilio Adriani, Petra Nytrova, Cyprien Mbogning, et al.
Annals of Neurology
|
July 7, 2017
Matrix metalloproteinase 9 is decreased in natalizumab-treated multiple sclerosis patients at risk for progressive multifocal leukoencephalopathy
Nicolas Fissolo, Béatrice Pignolet, Clara Matute-Blanch, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 26) with videos related to
Sort By:
Page
of 3
Journal of Neuroinflammation
|
April 17, 2015
Role of high mobility group box protein 1 (HMGB1) in peripheral blood from patients with multiple sclerosis
Sunny Malhotra, Nicolas Fissolo, Mar Tintoré, et al.
Blood
|
November 5, 2005
AID expression identifies interfollicular large B cells as putative precursors of mature B-cell malignancies
Gerhard Moldenhauer, Sergey W Popov, Beate Wotschke, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 21, 2009
Advanced intercross line mapping suggests that ncf1 (ean6) regulates severity in an animal model of guillain-barre syndrome
Alexander Huberle, Amennai Daniel Beyeen, Johan Ockinger, et al.
Frontiers in Immunology
|
August 10, 2023
Molecular signature associated with cladribine treatment in patients with multiple sclerosis
Nicolas Fissolo, Laura Calvo-Barreiro, Herena Eixarch, et al.
European Journal of Neurology
|
May 15, 2023
The CYP24A1 gene variant rs2762943 is associated with low serum 1,25-dihydroxyvitamin D levels in multiple sclerosis patients
Sunny Malhotra, Luciana Midaglia, Omar Chuquisana, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
July 10, 2018
Cerebrospinal fluid mitochondrial DNA levels in patients with multiple sclerosis
Nicolas Fissolo, Laura Cervera-Carles, Luisa María Villar Guimerans, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
September 9, 2021
CSF Chitinase 3-Like 2 Is Associated With Long-term Disability Progression in Patients With Progressive Multiple Sclerosis
Manuel Comabella, Jaume Sastre-Garriga, Eva Borras, et al.
Clinical and Translational Medicine
|
April 9, 2024
Clusterin deficiency is associated with a lack of response to teriflunomide in multiple sclerosis
Sunny Malhotra, Nicolas Fissolo, Carmen Rodríguez-Rivera, et al.
JCI Insight
|
June 8, 2018
Monocyte NOTCH2 expression predicts IFN-β immunogenicity in multiple sclerosis patients
Marsilio Adriani, Petra Nytrova, Cyprien Mbogning, et al.
Annals of Neurology
|
July 7, 2017
Matrix metalloproteinase 9 is decreased in natalizumab-treated multiple sclerosis patients at risk for progressive multifocal leukoencephalopathy
Nicolas Fissolo, Béatrice Pignolet, Clara Matute-Blanch, et al.
Page
of 3